CD8A and T-cell non-Hodgkin lymphoma: It has been reported that mice challenged with EL4 T-cell lymphoma cells genetically modified to produce murine CXCL11 attracted more CD8+ lymphocytes and macrophages with anti-tumoral activity to the TME compared to WT EL4 T-cell lymphoma cells [42].